Imatinib may be useful in the management of patients with glioblastoma.
Boruban
Cem
C
Yavas
Ozlem
O
Altundag
Ozden
O
Altundag
Muzaffer B
MB
Altundag
Kadri
K
D000970:Antineoplastic Agents / Q000627:therapeutic use; D001549:Benzamides; D001927:Brain Diseases / Q000532:radiotherapy*; D002986:Clinical Trials as Topic; D019317:Evidence-Based Medicine; D005909:Glioblastoma / Q000532:radiotherapy*; D006801:Humans; D000068877:Imatinib Mesylate; D010879:Piperazines / Q000627:therapeutic use*; D011743:Pyrimidines / Q000627:therapeutic use*; D011838:Radiation-Sensitizing Agents / Q000627:therapeutic use*
D000970:Antineoplastic Agents; D001549:Benzamides; D010879:Piperazines; D011743:Pyrimidines; D011838:Radiation-Sensitizing Agents; D000068877:Imatinib Mesylate